SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-020599
Filing Date
2024-03-07
Accepted
2024-03-07 08:00:20
Documents
6
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0201341-6k_immuron.htm 6-K 13709
2 TRAVELAN TO PROGRESS TO PHASE 3 CLINICAL TRIALS IN THE US ea0201341ex99-1_immuron.htm EX-99.1 64474
3 GRAPHIC image_001.jpg GRAPHIC 1289
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5290
5 GRAPHIC ex99-1_002.jpg GRAPHIC 6783
6 GRAPHIC ex99-1_003.jpg GRAPHIC 3305
  Complete submission text file 0001213900-24-020599.txt   102756
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 24728193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)